Crinetics Pharmaceuticals (CRNX) Non Operating Interest Expenses (2017)
Powered by 
Analysis
Crinetics Pharmaceuticals (CRNX) Non Operating Interest Expenses (2017) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.30 Bn | 131.45 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.70 Bn | 77.70 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.33 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 58.00 Bn | 52.86 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.18 Bn | 44.18 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.23 Bn | 31.93 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Crinetics Pharmaceuticals | 8.99 Bn | 8.99 Bn | 24.96 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 49,000.00 |
| Sep 30, 2017 | 2,000.00 |
| Jun 30, 2017 | 3,000.00 |